Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1488-1492

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lijnen, H. R.
Right arrow Articles by Collen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lijnen, H. R.
Right arrow Articles by Collen, D.
Related Collections
Right arrow Animal models of human disease
Right arrow Fibrinolysis
Right arrow Smooth muscle proliferation and differentiation
Right arrow Coagulation and fibronolysis
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1488.)
© 2000 American Heart Association, Inc.


Vascular Biology

{alpha}2-Antiplasmin Gene Deficiency in Mice Does Not Affect Neointima Formation After Vascular Injury

H. R. Lijnen; B. Van Hoef; M. Dewerchin; D. Collen

From the Center for Molecular and Vascular Biology (H.R.L., B.V.H., D.C.), University of Leuven, and the Center for Transgene Technology and Gene Therapy (M.D., D.C.), Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium.

Correspondence to H. R. Lijnen, PhD, Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, O & N, Herestraat 49, B-3000 Leuven, Belgium. E-mail roger.lijnen{at}med.kuleuven.ac.be

Abstract—The hypothesis that {alpha}2-antiplasmin ({alpha}2-AP), the main physiological plasmin inhibitor, plays a role in neointima formation was tested with use of a vascular injury model in wild-type ({alpha}2-AP+/+) and {alpha}2-AP–deficient ({alpha}2-AP-/-) mice. The neointimal and medial areas were similar 1 to 3 weeks after electric injury of the femoral artery in {alpha}2-AP+/+ and {alpha}2-AP-/- mice, resulting in comparable intima/media ratios (eg, 0.43±0.12 and 0.42±0.11 2 weeks after injury). Nuclear cell counts in cross-sectional areas of the intima of the injured region were also comparable in arteries from {alpha}2-AP+/+ and {alpha}2-AP-/- mice (78±19 and 69±8). Fibrin deposition was not significantly different in arteries of both genotypes 1 day after injury, and no mural thrombosis was detected 1 week after injury. Fibrinolytic activity in femoral arterial sections, as monitored by fibrin zymography, was higher in {alpha}2-AP-/- mice 1 week after injury (P<0.001) but was comparable in both genotypes 2 and 3 weeks after injury. Staining for elastin did not reveal significant degradation of the internal elastica lamina in either genotype. Immunocytochemical analysis revealed a comparable distribution pattern of {alpha}-actin–positive smooth muscle cells in both genotypes. These findings indicate that the endogenous fibrinolytic system of {alpha}2-AP+/+ mice is capable of preventing fibrin deposition after vascular injury and suggest that {alpha}2-AP does not play a major role in smooth muscle cell migration and neointima formation in vivo.


Key Words: neointima • restenosis • transgenic mice • {alpha}2-antiplasmin




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. P. Fay, N. Garg, and M. Sunkar
Vascular Functions of the Plasminogen Activation System
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1231 - 1237.
[Abstract] [Full Text] [PDF]